Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the m...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-10-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2298 |
_version_ | 1818883489155514368 |
---|---|
author | Silvia Ciotti Mary Micheli Antonella Cometa Claudia De Carlo Giancarlo Martini Andrea Marona Laura Filippetti Diego Carducci Silvano Baratta Mauro Zampolini Francesco Corea |
author_facet | Silvia Ciotti Mary Micheli Antonella Cometa Claudia De Carlo Giancarlo Martini Andrea Marona Laura Filippetti Diego Carducci Silvano Baratta Mauro Zampolini Francesco Corea |
author_sort | Silvia Ciotti |
collection | DOAJ |
description | Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the motor performance of patients with MS, causing pain, reduction in distance walked and limitations in social life. We present the case of a 39-year-old woman with MS. She was treated with delta-9-tetrahydrocannabinol/cannabidiol and the outcome was assessed with the International Classification of Functioning Disability and Health core set framework. |
first_indexed | 2024-12-19T15:34:28Z |
format | Article |
id | doaj.art-eefb9eb4af6f476d932ac8b39d05ecec |
institution | Directory Open Access Journal |
issn | 2284-2594 |
language | English |
last_indexed | 2024-12-19T15:34:28Z |
publishDate | 2021-10-01 |
publisher | SMC MEDIA SRL |
record_format | Article |
series | European Journal of Case Reports in Internal Medicine |
spelling | doaj.art-eefb9eb4af6f476d932ac8b39d05ecec2022-12-21T20:15:39ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942021-10-0110.12890/2021_0022981914Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and HealthSilvia Ciotti0Mary Micheli1Antonella Cometa2Claudia De Carlo3Giancarlo Martini4Andrea Marona5Laura Filippetti6Diego Carducci7Silvano Baratta8Mauro Zampolini9Francesco Corea10 USL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation, S.M. Stella, Orvieto, ItalyUSL Umbria 2, Department of Rehabilitation, Domus Gratiae, Terni, ItalyUSL Umbria 2, Department of Rehabilitation, Ospedale di Cascia, Cascia, ItalyDepartment of Neuroradiology, USL Umbria 2, Ospedale S.G. Battista, Foligno, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, Italy USL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista, Foligno, Italy USL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista, Foligno, Italy USL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista, Foligno, ItalyMultiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the motor performance of patients with MS, causing pain, reduction in distance walked and limitations in social life. We present the case of a 39-year-old woman with MS. She was treated with delta-9-tetrahydrocannabinol/cannabidiol and the outcome was assessed with the International Classification of Functioning Disability and Health core set framework.https://www.ejcrim.com/index.php/EJCRIM/article/view/2298multiple sclerosisicfneurorehabilitationdelta-9-tetrahydrocannabinol/cannabidiol |
spellingShingle | Silvia Ciotti Mary Micheli Antonella Cometa Claudia De Carlo Giancarlo Martini Andrea Marona Laura Filippetti Diego Carducci Silvano Baratta Mauro Zampolini Francesco Corea Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health European Journal of Case Reports in Internal Medicine multiple sclerosis icf neurorehabilitation delta-9-tetrahydrocannabinol/cannabidiol |
title | Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health |
title_full | Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health |
title_fullStr | Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health |
title_full_unstemmed | Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health |
title_short | Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health |
title_sort | treatment with delta 9 tetrahydrocannabinol cannabidiol in multiple sclerosis influence on the autonomy profile according to the international classification of functioning disability and health |
topic | multiple sclerosis icf neurorehabilitation delta-9-tetrahydrocannabinol/cannabidiol |
url | https://www.ejcrim.com/index.php/EJCRIM/article/view/2298 |
work_keys_str_mv | AT silviaciotti treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT marymicheli treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT antonellacometa treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT claudiadecarlo treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT giancarlomartini treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT andreamarona treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT laurafilippetti treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT diegocarducci treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT silvanobaratta treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT maurozampolini treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth AT francescocorea treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth |